首页> 中文期刊> 《中国卫生标准管理》 >莫西沙星或左氧氟沙星用于耐多药肺结核治疗中的临床效果

莫西沙星或左氧氟沙星用于耐多药肺结核治疗中的临床效果

             

摘要

Objective To study moxifloxacin or levofloxacin for clinical effect in the treatment of multi drug resistant pulmonary tuberculosis. MethodsOur hospital were treated multi-drug resistant tuberculosis patients 62 cases between December 2013 and December 2014. They were divided into two groups,group A was treated with moxifloxacin,group B was treated with levofloxacin,analysis of two groups of therapeutic effect.ResultsAfter treatment the total effective rate of group A was higher than group B(P<0.05). But the adverse reactions to compare differences between the two groups,P>0.05.Conclusion Using moxifloxacin in treatment of multi-drug resistant tuberculosis,the effect is remarkable.%目的:研究莫西沙星或左氧氟沙星治疗耐多药肺结核的临床效果。方法选取我院2013年12月~2014年12月收治的耐多药肺结核病患者62例,分为两组,A组用莫西沙星治疗,B组用左氧氟沙星治疗,分析两组治疗效果。结果 A组治疗后的总有效率高于B组(P<0.05);两组不良反应比较差异无统计学意义(P>0.05)。结论采用莫西沙星治疗耐多药肺结核的效果突出。

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号